Preclinical Alzheimer disease: Neuropsychological test performance 1.5 to 8 years prior to onset

Neurology

Volumn 63, Issue 12, 2004, Pages 2341-2347

  Saxton, Judith ^a   Lopez, O L ^a   Ratcliff, G ^b   Dulberg, C ^c   Fried, L P ^d   Carlson, M C ^d   Newman, A B ^a   Kuller, L ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b HealthSouth Harmarville Rehabilitation Hospital   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL STUDY; COGNITIVE DEFECT; DEMENTIA; FEMALE; FOLLOW UP; HUMAN; INTELLIGENCE TEST; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 11144302567     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000147470.58328.50     Document Type: Article

References (43)

1. Price JL, Morris JC. Tangles and plaques in nondemented aging and 'preclinical' Alzheimer's disease. Ann Neurol 1999;45:358-368.
2. DeKosky S, Ikonomovic M, Styren S, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002;51:145-155.
3. Morris JC, Storandt M, McKeel DW Jr., et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996;46: 707-719.
4. Tierney MC, Szalai JP, Snow WG, et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 1996;46:661-665.
5. Small BJ, Fratiglioni L, Vitanen M, et al. The course of cognitive impairment in preclinical Alzheimer's disease: three- and 6-year follow-up of a population-based sample. Arch Neurol 2000;57:839-844.
6. Touchon J, Richie K. Prodromal cognitive disorder in Alzheimer's disease. Int J Geriatr Psychol 1999;14:556-563.
7. Rubin EH, Storandt M, Miller JP, et al. A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol 1998;55:395-401.
8. Elias MF, Beiser A, Wolf PA, et al. The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham cohort. Arch Neurol 2000;57:808-813.
9. Bäckman L, Small BJ, Fratiglioni L. Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain 2001;124:96-102.
10. Chen P, Ratcliff G, Belle SH, et al. Patterns of cognitive decline in presymptomatic Alzheimer Disease. Arch Gen Psychiatry 2001;58:853-858.
11. Howieson DB, Dame A, Camicioli R, et al. Cognitive markers preceding Alzheimer's dementia in the healthy oldest old. J Am Geriatr Soc 1997; 45:584-589.
12. Collie A, Maruff P. The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosci Biobehav Rev 2000;24: 365-374.
13. Fried LP, Borhani NO, Enright P, et al. CHS: the Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1991;1:263-276.
14. Tell GS, Fried LP, Hermanson B, et al. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 1993;3:358-366.
15. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatry 1987;48:314-318.
16. Wechsler D. WAIS-R manual. New York: The Psychological Corporation, 1981.
17. Gallo JJ, Breitner JCS. Alzheimer's disease in the NAS-NRC Registry of ageing twin veterans, IV. Performance characteristics of a two-stage telephone screening procedure for Alzheimer's dementia. Psychol Med 1995;25:1211-1219.
18. rd ed. New York: Psychological Corporation, 1963.
19. Jorm AF, Jacomb PA. The informant questionnaire on cognitive decline in the elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989;19:1015-1022.
20. Kawas C, Segal J, Stewart WF, et al. A validation study of the dementia questionnaire. Arch Neurol 1994;51:901-906.
21. Fried LP, Kronmal RA, Newman A, et al. Risk factors for 5-year mortality in older adults: The Cardiovascular Health Study. JAMA 1998; 279:585-592.
22. Saxton J, Ratcliff G, Newman A, et al. Cognitive test performance and presence of subclinical cardiovascular disease in the Cardiovascular Health Study. Neuroepidemiology 2000;19:312-319.
23. Wechsler D. Wechsler Memory Scale-Revised manual. San Antonio, TX: The Psychological Corporation, 1987.
24. Reitan RM. Validity of the Trail Making test as an indicator of organic brain damage. Percep Mot Skills 1958;8:271-276.
25. Benton AL. Differential behavioral effects in frontal lobe disease. Neuropsychologia 1968;6:53-60.
26. Thurstone L. Primary mental abilities. Chicago: University of Chicago Press, 1938.
27. Kaplan ER, Goodglass H, Weintraub S. The Boston Naming Test (2 ed.) Philadelphia: Lea & Febiger, 1983.
28. Lopez OL, Kuller LH, Fitzpatrick A, et al. Evaluations of dementia in the Cardiovascular Health Cognitive Study. Neuroepidemiology 2003; 22:1-12.
29. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
30. Fahn S, Elton RI. UPDRS Development Committee: Unified Parkinson's Rating Scale. In: Fahn S, Marsden CD, Caine D, Goldstein M, eds. Recent developments in Parkinson's disease. Florham Park: MacMillan Healthcare Information, 1987;153-163.
31. Hachinski VC, Iliff L'D, Zihka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637.
32. McKhann G, Drachman D, Folstein, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
33. Braak H, Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand 1996;165:3-12.
34. Martin A, Fedio P. Word production and comprehension in Alzheimer's disease: The breakdown of semantic knowledge. Brain Lang 1983;19: 124-141.
35. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
36. Delacourte A. Biochemical and molecular characterization of neurofibrillary degeneration in frontotemporal dementias. Dementia Geriatr Cogn Disord 1999;10(Suppl 1):75-79.
37. Snowdon D, Ostwald S, Kane R. Education, survival, and independence in elderly Catholic sisters, 1936-88. Am J Epidemiol 1989;130:999-1012.
38. Snowdon D, Ostwald S, Kane RL, et al. Years of life with good and poor mental and physical function in the elderly. J Clin Epidemiol 1989;42: 1055-1066.
39. Plassman BL, Welsh KA, Helms M, et al. Intelligence and education as predictors of cognitive state in late life: a 50-year follow-up. Neurology 1995;45:1446-1450.
40. Evans DA, Hebert LE, Beckett LA, et al. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Arch Neurol 1997;54:1399-1405.
41. Mortimer JA, Graves AB. Education and other socioeconomic determinants of dementia and Alzheimer's disease. Neurology 1993;43:S39-S44.
42. Satz P. Brain reserve capacity on symptom onset after brain injury: a formulation and review of evidence for threshold theory. Neuropsychology 1993;7:273-295.
43. Coffey CE, Saxton JA, Ratcliff G, et al. Relation of education to brain size in normal aging. Implications for the reserve hypothesis. Neurology 1999;53:189-196.